BioAdaptives Inc. (BDPT)

Every figure this model derived for BDPT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 18,000 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 29,221 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 67,767 AssetsCurrent 2026-06-30
current liabilities 1,844,874 LiabilitiesCurrent 2026-06-30
equity -1,766,107 StockholdersEquity 2026-06-30
interest expense 52,220 InterestExpense 2026-06-30
ocf -436,361 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 25,561 Revenues 2026-06-30
sbc 28,670 ShareBasedCompensation 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up BDPT on one particular measure came for.

RatioValue
current ratio0.04
current ratio reported0.04
dilution pct22.62
ev owner earnings-1.53
ev sales28.84
fcf margin-1777.56
growth cv3.42
interest cover-17.41
revenue growth694.07
revenue growth per share547.57
rule of 40-2862.91
sbc pct revenue112.16

What to be careful about

What this model itself distrusts about BDPT's figures. Written by the derivation as it ran, not added afterwards.